CPC C07K 16/241 (2013.01) [A61K 9/0019 (2013.01); A61K 38/191 (2013.01); A61K 39/4636 (2023.05); C07K 14/52 (2013.01); C07K 16/2827 (2013.01); C07K 16/2875 (2013.01); A61K 38/00 (2013.01); A61K 39/001129 (2018.08); C07K 2319/00 (2013.01)] | 20 Claims |
1. A method for treating cancer in a mammal, comprising a step of administering to said mammal a therapeutically effective amount of a disulfide bond-linked trimeric OX40L fusion protein, wherein the disulfide bond-linked trimeric OX40L fusion protein comprises the amino acid sequence set forth in SEQ ID NO: 5 or SEQ ID NO: 6.
|